THERAPEUTICSMD INC stock forecast: down to 2.33 USD TXMD stock price prognosis

STOCK

Forecast for Fri 12 Jan 2024 price 2.35

THERAPEUTICSMD INC stock price forecast for further price development down to -44.24% (time horizon: 1 day) and price target of 2.33 USD. Negative news sentiment. Short-term (time horizon: 2 weeks) THERAPEUTICSMD INC share price prediction for 2024-01-12 with daily closed price projections

Key Facts

Symbol TXMD 

ISIN US88338N1072 

CUSIP 88338N107


Currency USD


Category Pharmaceutical Preparations

Forecast price change %


News sentiment (-1.00)


News <--> Close correlation for next day influence (-0.38)

Finance numbers

Revenue 72,485,000.0


Earnings per share -0.57


On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

Healthcare has become increasingly consumer driven. We supply our prescription products to consumers through pharmacies nationwide. Focus on Hormone Therapy Products. EE is an approved active ingredient in many marketed hormonal contraceptive products. Additionally, KAMs are focusing on supporting current prescribers of BIJUVA. We do this while working to negotiate the best possible contracts for us. We may also terminate the Theramex License Agreement if Theramex challenges our patents. We have also placed on hold our oral progesterone and estradiol formulation (TX-009HR). The foreign patents will expire no earlier than 2033. Additional exclusivities may also apply. The IMVEXXY Patents identified in the IMVEXXY Notice Letter expire in 2032 or 2033. The BIJUVA Patents identified in the Notice Letter expire in 2032. In addition, these laws and their interpretations are subject to change. These issues may take years to resolve. We believe the risks and uncertainties described below are the most significant we face. 9679; Our success is tied to our distribution channels. &# As of December 31, 2020, we had an accumulated deficit of approximately $879 million. These changes will likely result in new agency priorities, rulemakings, and legislation. Any such dispute could have an adverse effect on our business. In addition, there is a natural transition period when a new CRO commences work. Claims could also be asserted under state consumer fraud and protection statutes. In some instances, our products have unique ingredients used under license arrangements. Clinical trials may be suspended or terminated at any time for many reasons.

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/25743/000138713121003140/0001387131-21-003140.txt
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 25.19/100
    • Not in ideal financial position.
    • Historical view, profit is growing.
    • Company revenue is not growing faster compared with the industry.
    • Stock price is under book price value.

Institutional ownership list is based on filling form information

Holding name Date Amount
MetLife Investment Management, LLC 2021-09-30 148607
MetLife Investment Management, LLC 2021-06-30 50194
MetLife Investment Management, LLC 2021-03-31 142269
MetLife Investment Management, LLC 2020-12-31 20365
MetLife Investment Management, LLC 2020-09-30 42066

Insider trading for THERAPEUTICSMD INC

CIK Name Date Action T-Test 1day T-Test 7day T-Test 14day T-Test 30day
1627810 Donegan Michael C 2023-01-26 SALE Accept Accept Accept Accept


Bollinger Bollinger Bands for THERAPEUTICSMD INC can provide the information where the market is moving based on price information.


THERAPEUTICSMD INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.



Converting prices to returns THERAPEUTICSMD INC.


On-Balance Volume information for THERAPEUTICSMD INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.



Accumulation / Distribution (A/D) indicator information for THERAPEUTICSMD INC. The indicator identify divergences between price and volume flow.


Aroon Oscillator information for THERAPEUTICSMD INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.


Average Directional Index (ADX) information for THERAPEUTICSMD INC. The index can be used to identify the strengh of a trend.


Moving Average Convergence Divergence (MACD) for THERAPEUTICSMD INC. The indicator helps to predict trend direction and the momentum of the trend.


Stochastic Oscillator as momentum indicator for THERAPEUTICSMD INC. The indicator is useful for identifying overbought and oversold levels.


Relative Strength Index (RSI) for THERAPEUTICSMD INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].


Heikin Ashi trading signals are generated based on the Heikin Ashi candles, which are a type of candlestick that smooths out the price action and can help to identify trends. Heikin Ashi signals can be used to identify both long and short trading opportunities.


The awesome oscillator is a momentum indicator that measures the speed and strength of price movements. It is calculated by subtracting a 34-period simple moving average (SMA) from a 5-period SMA.


The Parabolic SAR indicator is a trend-following indicator that uses a series of dots to indicate when a trend is likely to reverse. The Parabolic SAR is a lagging indicator, meaning that it does not predict reversals, but rather confirms them after they have already occurred.


52W High 52W Low Market Cap

Similar shares


THERAPEUTICSMD INC on Nasdaq

THERAPEUTICSMD INC on finviz

Figure below show the stock predictions.
Date Closing price Prediction was updated
2024-01-01 2.33 2023-11-18 07:49
2024-01-02 2.33 2023-11-18 07:49
2024-01-03 2.34 2023-11-18 07:49
2024-01-04 2.34 2023-11-18 07:49
2024-01-05 2.34 2023-11-18 07:49
2024-01-12 2.35 2023-11-18 07:49
2023-12-13 2.29 2023-11-18 07:49
2023-12-14 2.29 2023-11-18 07:49
2024-01-08 2.34 2023-11-18 07:49
2024-01-09 2.35 2023-11-18 07:49
2023-12-18 2.30 2023-11-18 07:49
2023-12-19 2.31 2023-11-18 07:49
2023-12-20 2.31 2023-11-18 07:49
2023-12-11 2.29 2023-11-18 07:49
2023-12-12 2.28 2023-11-18 07:49
2023-12-15 2.30 2023-11-18 07:49
2023-12-21 2.31 2023-11-18 07:49
2024-01-10 2.35 2023-11-18 07:49
2023-12-22 2.31 2023-11-18 07:49
2023-12-25 2.31 2023-11-18 07:49
2024-01-11 2.35 2023-11-18 07:49
2023-12-26 2.32 2023-11-18 07:49
2023-12-27 2.32 2023-11-18 07:49
2023-12-28 2.32 2023-11-18 07:49
2023-12-29 2.33 2023-11-18 07:49

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.